| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |